Targeted Genetics Corporation, Mainstay of Gene Therapy, Faces Likely Shutdown

Published: May 08, 2009

Xconomy -- Targeted Genetics, one of the diehards in the field of gene therapy, appears to be near the end of the road. The Seattle-based biotech company said if it is unable to improve its finances by the end of next month, “We plan to begin the process of ceasing operations, seeking bankruptcy protection or otherwise winding up our business,” according to its quarterly filing with the SEC.

Back to news